Clinical Microbiology and Antimicrobial Chemotherapy. 2004; 6(1):32-50
In vitro studies and animal models have shown that clinical efficacy of β-lactams depends on the duration of time plasma drug concentration needed to exceed the minimal inhibitory concentration for causative microorganism (time above MIC). In …